🔎 Trials Near Me

Beranda › Kanker Kandung Kemih › California › Los Angeles

Uji klinis Kanker Kandung Kemih di Los Angeles, CA

24 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Menerima pesertaFase 2
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06770582

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Menerima pesertaFase 1
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Menerima pesertaFase 2
  • USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Menerima pesertaFase 2
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07061964

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Menerima pesertaFase 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Menerima pesertaFase 2
  • Keck Medicine of USC Koreatown, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Menerima pesertaFase 1/2
  • START Los Angeles, LLC, Los Angeles
  • Los Angeles Cancer Network - Century City, Los Angeles
  • (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Menerima pesertaFase 3
  • TRIO-US (Translational Research in Oncology-US), Los Angeles
  • UCLA Hematology/Oncology - Santa Monica, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07218380

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Menerima pesertaFase 1
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07217171

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Menerima pesertaFase 2/3
  • Research Site, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07129993

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Menerima pesertaFase 1
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05614739

A Study of MGC026 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • The Angeles Clinic and Research Institute, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Menerima pesertaFase 1/2
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Tower Urology, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT04752722

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Menerima pesertaFase 2
  • UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
  • Kaiser Permanente Los Angeles Medical Offices, Los Angeles
  • Kaiser Permanente West Los Angeles Medical Center, Los Angeles
  • dan 6 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT04879329

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

Menerima pesertaFase 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07337525

Predicting BCG Response

Menerima pesertaStudi observasional
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA, Los Angeles
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04564781

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Menerima pesertaFase 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • The Regents of the University of California, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04389632

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Menerima peserta
  • Urology Group of Southern California, Los Angeles
  • Comprehensive Urology, Los Angeles
Usia 18 hingga 88 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT06394869

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Menerima pesertaFase 1
  • USC - Norris Comprehensive Cancer Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Menerima pesertaStudi observasional
  • Cedars-Sinai Medical Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT03193515

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Menerima pesertaStudi observasional
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA Medical Center, Los Angeles
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT03193541

Blue Light Cystoscopy With Cysview® Registry

Menerima pesertaStudi observasional
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • University of California Los Angeles, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Des 2025 · NCT02660645

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Menerima peserta
  • Cedars-Sinai Medical Center (CSMC), Los Angeles
  • University of California Los Angeles, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2025 · NCT04442724

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Menerima peserta
  • UCLA, Los Angeles
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 12 Feb 2025 · NCT06337942

Uji klinis Kanker Kandung Kemih di kota lain

Studi lain di Los Angeles

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.